Roger Bouillon's scientific contributions

Vitamin D plays an important role in calcium homeostasis and many cellular processes. Although vitamin D supplements are widely recommended for community dwelling adults, definitive data on whether these supplements benefit clinically important skeletal and extra-skeletal outcomes have been conflicting. While observational studies on effects of vitamin D on musculoskeletal and extra-skeletal outcomes may be confounded by reverse causation, randomized controlled studies (RCTs) and Mendelian Randomization (MR) studies can help to elucidate causation. In this review we summarize the recent findings from large RCTs and/or MR studies of vitamin D on bone health and risk of fractures, falls, cancer, and cardiovascular disease, disorders of the immune system, multiple sclerosis, and mortality in community-dwelling adults. The primary analyses indicate that vitamin D supplementation does not decrease bone loss, fractures, falls, cancer incidence, hypertension, or cardiovascular risk in generally healthy populations. Large RCTS and meta-analyses suggest an effect of supplemental vitamin D on cancer mortality. The existence of extra-skeletal benefits of vitamin D supplementations are best documented for the immune system especially in people with poor vitamin D status, autoimmune diseases and multiple sclerosis. Accumulating evidence indicates that vitamin D may reduce all-cause mortality. These findings, in mostly vitamin D replete populations, do not apply to older adults in residential communities or adults with vitamin D deficiency or osteoporosis. The focus of vitamin D supplementation should shift from widespread use in generally healthy populations to targeted vitamin D supplementation in select individuals, good nutritional approaches, and elimination of vitamin D deficiency globally. This article is protected by copyright. All rights reserved.